Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Apr;83(4):392-6.
doi: 10.1111/j.1349-7006.1992.tb00120.x.

In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin

M Iigo  1 , K Nishikata, A Hoshi
Affiliations

In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin

M Iigo et al. Jpn J Cancer Res. 1992 Apr.

Abstract

Antitumor effect and active metabolites of fluoropyrimidines were examined in mice with transplantable colon adenocarcinoma 38 (Co 38). 5-Fluoro-2'-deoxyuridine (FUdR) treatment resulted in a much higher level of free 5-fluoro-2'-deoxyuridine-5'-monophosphate in the tumor than 5-fluorouracil (5-FU) did, and thymidylate synthase was almost completely inhibited after FUdR treatment, but FUdR showed weaker antitumor activity than 5-FU did. Moreover, 5-fluorouridine (FUR) also hardly inhibited tumor growth. A more marked tumor inhibition was obtained when FUdR and FUR were administered together. The antitumor activity of 5-FU was similar to that of the combination of FUdR and FUR. In combination with 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, FUdR lost its antitumor activity, but that of FUR was somewhat potentiated. On the other hand, in combination with leucovorin (LV), 5-FU showed markedly potentiated antitumor activity, while the antitumor activity of FUdR or FUR was not potentiated. Addition of LV to the combination of FUdR and FUR enhanced the inhibitory effect of the drugs. From these results, the combination of FUdR and FUR together with LV, and the combination of 5-FU and LV seem to be highly efficacious against Co 38.

PubMed Disclaimer

References

    1. ) Machover , D. , Schwarzenberg , L. , Goldschmidt , E. , Tourane , J. E. , Michalski , B. , Hatat , M. , Dorval , T. , Misset , J. L. , Jasmin , C , Maral , R. and Mathe , G.Treatment of advanced colorectal and gastric adenocarcinomas with 5‐fluorouracil combined with high‐dose folinic acid: a pilot study . Cancer Treat. Rep. , 66 , 1803 – 1807 ( 1982. ). - PubMed
    1. ) Nobile , M. T. , Sertoli , M. R. , Bruzzone , M. , Tagarelli , G.Rubagotti , A. and Rosso , R.Phase II study with high dose N5,10methylenetetrahydrofolate and 5‐fluorouracil in advanced colorectal cancer . Eur. J. Cancer Clin. Oncol , 21 , 1175 – 1177 ( 1985. ). - PubMed
    1. ) Budd , G. T. , Schreiber , M. J. , Steiger , E. , Bukowski , R. and Weick , J.Phase I trial of intraperitoneal chemotherapy with 5‐fluorouracil and citrovorum factor . Invest. New Drugs , 4 , 155 – 158 ( 1986. ). - PubMed
    1. ) Madajewicz , S. , Petrelli , N. , Rustum , Y. M. , Campbell , J. , Herrena , L. , Mittelman , A. , Perri , A. and Creaven , P. J.Phase I‐II trial of high dose calcium leucovorin and 5‐fluorouracil in advanced colorectal cancer . Cancer Res. , 44 , 4667 – 4669 ( 1984. ). - PubMed
    1. ) Arbuck , S. G. , Trave , F. , Douglass , H. O. , Nava , H. , Zakrzewski , S. and Rustum , Y. M.Phase I and pharmacologic studies of intraperitoneal leucovorin and 5‐fluorouracil in patients with advanced cancer . J. Clin. Oncol. , 4 , 1510 – 1517 ( 1986. ). - PubMed

Publication types

MeSH terms

LinkOut - more resources